Abdul M Gbaj

562 total citations
49 papers, 469 citations indexed

About

Abdul M Gbaj is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Abdul M Gbaj has authored 49 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Abdul M Gbaj's work include Synthesis and biological activity (10 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Abdul M Gbaj is often cited by papers focused on Synthesis and biological activity (10 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Abdul M Gbaj collaborates with scholars based in Libya, United Kingdom and Austria. Abdul M Gbaj's co-authors include Kenneth T. Douglas, Sally Freeman, Ian J. Stratford, Philip Reigan, Philip N. Edwards, Mohammed Jaffar, Anton Hermann, Richard A. Bryce, Elena V. Bichenkova and Christian Cole and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and European Journal of Medicinal Chemistry.

In The Last Decade

Abdul M Gbaj

45 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdul M Gbaj Libya 14 219 212 111 48 38 49 469
Mohammad Nadeem Lone India 9 157 0.7× 313 1.5× 103 0.9× 42 0.9× 26 0.7× 13 583
Hatem A Hejaz Palestinian Territory 13 380 1.7× 188 0.9× 66 0.6× 24 0.5× 43 1.1× 27 657
Suresh Kumar Chitta India 14 198 0.9× 112 0.5× 85 0.8× 23 0.5× 24 0.6× 23 384
Thummaruk Suksrichavalit Thailand 12 139 0.6× 191 0.9× 113 1.0× 56 1.2× 14 0.4× 16 481
Vinod Devaraji India 14 163 0.7× 309 1.5× 64 0.6× 91 1.9× 17 0.4× 28 505
Xianchao Pan China 13 164 0.7× 127 0.6× 65 0.6× 68 1.4× 11 0.3× 39 402
Keith C. Ellis United States 15 309 1.4× 300 1.4× 43 0.4× 21 0.4× 24 0.6× 28 682
Thomas V. Magee United States 10 207 0.9× 320 1.5× 175 1.6× 49 1.0× 20 0.5× 12 546
Hadia Almahli United Kingdom 17 371 1.7× 529 2.5× 99 0.9× 58 1.2× 27 0.7× 30 749
Thierry Lomberget France 16 256 1.2× 454 2.1× 49 0.4× 33 0.7× 13 0.3× 46 708

Countries citing papers authored by Abdul M Gbaj

Since Specialization
Citations

This map shows the geographic impact of Abdul M Gbaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul M Gbaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul M Gbaj more than expected).

Fields of papers citing papers by Abdul M Gbaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdul M Gbaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul M Gbaj. The network helps show where Abdul M Gbaj may publish in the future.

Co-authorship network of co-authors of Abdul M Gbaj

This figure shows the co-authorship network connecting the top 25 collaborators of Abdul M Gbaj. A scholar is included among the top collaborators of Abdul M Gbaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdul M Gbaj. Abdul M Gbaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hermann, Anton, et al.. (2020). Novel ortho- phenylenediamine derivatives as spike glycoprotein coronavirus 2019-nCoV inhibitors: molecular docking study. MOJ Anatomy & Physiology. 7(3). 70–74. 1 indexed citations
3.
Hermann, Anton, et al.. (2020). Characterization of Libyan Cobra (Naja haje) Venom UsingFluorescence and UV-Visible Spectroscopy. 4(5). 9–13. 1 indexed citations
4.
Morsy, Nesrin M., et al.. (2020). Synthesis, antitumor activity, enzyme assay, DNA binding and molecular docking of Bis-Schiff bases of pyrazoles. Journal of the Iranian Chemical Society. 18(1). 47–59. 39 indexed citations
5.
Hermann, Anton, et al.. (2020). Evaluation of aerial parts of Echium angustifolium on ciguatoxins toxicity using molecular modeling and albino mice models. MOJ Anatomy & Physiology. 7(5). 134–145. 2 indexed citations
6.
7.
Gbaj, Abdul M, et al.. (2014). Cytotoxic activity of Helianthemum Lippii. 8(2). 92–94. 3 indexed citations
8.
Hermann, Anton, et al.. (2013). Phytochemical, anti-oxidant, anti-microbial, anti-inflammatory and anti-ulcer properties of Helianthemum lippii. Journal of Pharmacognosy and Phytochemistry. 2(2). 86–96. 13 indexed citations
9.
Hermann, Anton, et al.. (2013). Design, synthesis, molecular modeling, and biological evaluation of sulfanilamide-imines derivatives as potential anticancer agents. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(9). 813–822. 16 indexed citations
10.
Hermann, Anton, et al.. (2012). Study of eight medicinal plants for antioxidant activities. Journal of chemical and pharmaceutical research. 4028–4031. 10 indexed citations
11.
Hermann, Anton, et al.. (2012). Screening of analgesic and anti-inflammatory activi ties for two Libyan medicinal plants: Helianthemum lippii and Launaea residifolia. Journal of chemical and pharmaceutical research. 4201–4205. 10 indexed citations
12.
Azam, Faizul, et al.. (2012). Structure-based design, synthesis, molecular docking, and biological activities of 2-(3-benzoylphenyl) propanoic acid derivatives as dual mechanism drugs. Journal of Pharmacy And Bioallied Sciences. 4(1). 43–43. 15 indexed citations
13.
Kadirvel, Manikandan, et al.. (2012). myo-Inositol esters of indomethacin as COX-2 inhibitors. Carbohydrate Research. 355. 13–18. 3 indexed citations
14.
Gbaj, Abdul M, Elena V. Bichenkova, H. Savage, et al.. (2008). New Concepts of Fluorescent Probes for Specific Detection of DNA Sequences: Bis-Modified Oligonucleotides in Excimer and Exciplex Detection. Libyan Journal of Medicine. 4(4). 152–159. 1 indexed citations
15.
Gbaj, Abdul M, et al.. (2008). SNP Detection for Cytochrome P450 Alleles by Target-assembled Tandem Oligonucleotide Systems Based on Exciplexes. Journal of Biomolecular Structure and Dynamics. 25(6). 629–640. 3 indexed citations
16.
Reigan, Philip, Abdul M Gbaj, Ian J. Stratford, Richard A. Bryce, & Sally Freeman. (2007). Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors. European Journal of Medicinal Chemistry. 43(6). 1248–1260. 15 indexed citations
17.
Gbaj, Abdul M, Philip N. Edwards, Philip Reigan, et al.. (2006). Thymidine phosphorylase fromEscherichia coli: Tight-binding inhibitors as enzyme active-site titrants. Journal of Enzyme Inhibition and Medicinal Chemistry. 21(1). 69–73. 18 indexed citations
18.
Kikuchi, Yo, et al.. (2005). Porphyrins and porphines bind strongly and specifically to tRNA, precursor tRNA and to M1 RNA and inhibit the ribonuclease P ribozyme reaction. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1730(1). 47–55. 10 indexed citations
19.
Reigan, Philip, Abdul M Gbaj, Edwin C. Chinje, et al.. (2004). Synthesis and enzymatic evaluation of xanthine oxidase-activated prodrugs based on inhibitors of thymidine phosphorylase. Bioorganic & Medicinal Chemistry Letters. 14(21). 5247–5250. 18 indexed citations
20.
Cole, Christian, Philip Reigan, Abdul M Gbaj, et al.. (2002). Potential Tumor-Selective Nitroimidazolylmethyluracil Prodrug Derivatives:  Inhibitors of the Angiogenic Enzyme Thymidine Phosphorylase. Journal of Medicinal Chemistry. 46(2). 207–209. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Nadeem Lone Breakdown of academic impact, for papers by Hatem A Hejaz Breakdown of academic impact, for papers by Suresh Kumar Chitta Breakdown of academic impact, for papers by Thummaruk Suksrichavalit Breakdown of academic impact, for papers by Vinod Devaraji Breakdown of academic impact, for papers by Xianchao Pan Breakdown of academic impact, for papers by Keith C. Ellis Breakdown of academic impact, for papers by Thomas V. Magee Breakdown of academic impact, for papers by Hadia Almahli Breakdown of academic impact, for papers by Thierry Lomberget
Rankless by CCL
2026